RhumbLine Advisers’s Lifestance Health LFST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05M | Buy |
204,013
+8,267
| +4% | +$42.7K | ﹤0.01% | 2214 |
|
2025
Q1 | $1.3M | Buy |
195,746
+165
| +0.1% | +$1.1K | ﹤0.01% | 2046 |
|
2024
Q4 | $1.44M | Buy |
195,581
+8,487
| +5% | +$62.5K | ﹤0.01% | 2063 |
|
2024
Q3 | $1.31M | Buy |
187,094
+4,963
| +3% | +$34.7K | ﹤0.01% | 2120 |
|
2024
Q2 | $894K | Buy |
182,131
+27,280
| +18% | +$134K | ﹤0.01% | 2306 |
|
2024
Q1 | $955K | Buy |
154,851
+2,379
| +2% | +$14.7K | ﹤0.01% | 2277 |
|
2023
Q4 | $1.19M | Sell |
152,472
-2,597
| -2% | -$20.3K | ﹤0.01% | 2163 |
|
2023
Q3 | $1.07M | Buy |
155,069
+8,905
| +6% | +$61.2K | ﹤0.01% | 2169 |
|
2023
Q2 | $1.33M | Buy |
146,164
+30,933
| +27% | +$282K | ﹤0.01% | 2145 |
|
2023
Q1 | $856K | Buy |
115,231
+4,249
| +4% | +$31.6K | ﹤0.01% | 2197 |
|
2022
Q4 | $548K | Buy |
110,982
+1,417
| +1% | +$7K | ﹤0.01% | 2422 |
|
2022
Q3 | $725K | Buy |
109,565
+6,076
| +6% | +$40.2K | ﹤0.01% | 2318 |
|
2022
Q2 | $575K | Buy |
103,489
+30,746
| +42% | +$171K | ﹤0.01% | 2422 |
|
2022
Q1 | $735K | Buy |
72,743
+24,252
| +50% | +$245K | ﹤0.01% | 2257 |
|
2021
Q4 | $462K | Buy |
48,491
+472
| +1% | +$4.5K | ﹤0.01% | 2541 |
|
2021
Q3 | $696K | Buy |
+48,019
| New | +$696K | ﹤0.01% | 2398 |
|